Boxer Capital as of Sept. 30, 2024
Portfolio Holdings for Boxer Capital
Boxer Capital holds 68 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Revolution Medicines (RVMD) | 9.5 | $194M | 4.3M | 45.35 | |
Tyra Biosciences (TYRA) | 7.4 | $152M | 6.4M | 23.51 | |
Nuvalent Inc-a (NUVL) | 5.6 | $115M | 1.1M | 102.30 | |
BeiGene Sponsored Adr | 5.5 | $112M | 500k | 224.51 | |
Cytokinetics Com New (CYTK) | 5.4 | $111M | 2.1M | 52.80 | |
Springworks Therapeutics (SWTX) | 5.4 | $110M | 3.4M | 32.04 | |
Merus N V (MRUS) | 4.7 | $95M | 1.9M | 49.96 | |
Sarepta Therapeutics (SRPT) | 4.0 | $81M | 650k | 124.89 | |
Avidity Biosciences Ord (RNA) | 3.9 | $79M | 1.7M | 45.93 | |
Ideaya Biosciences (IDYA) | 3.4 | $70M | 2.2M | 31.68 | |
Tango Therapeutics (TNGX) | 3.1 | $63M | 8.2M | 7.70 | |
Argenx SE Sponsored Adr (ARGX) | 2.7 | $54M | 100k | 542.08 | |
Apellis Pharmaceuticals (APLS) | 2.4 | $50M | 1.7M | 28.84 | |
Akero Therapeutics (AKRO) | 2.4 | $48M | 1.7M | 28.69 | |
Anaptysbio Inc Common (ANAB) | 2.1 | $44M | 1.3M | 33.50 | |
Axsome Therapeutics (AXSM) | 1.8 | $36M | 400k | 89.87 | |
Iteos Therapeutics (ITOS) | 1.5 | $30M | 2.9M | 10.21 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 1.4 | $29M | 600k | 48.73 | |
Geron Corporation (GERN) | 1.3 | $27M | 6.0M | 4.54 | |
Third Harmonic Bio (THRD) | 1.3 | $27M | 2.0M | 13.55 | |
Rocket Pharmaceuticals (RCKT) | 1.3 | $27M | 1.5M | 18.47 | |
Arcus Biosciences Incorporated (RCUS) | 1.2 | $25M | 1.6M | 15.29 | |
Instil Bio Com New (TIL) | 1.2 | $24M | 356k | 67.32 | |
Xenon Pharmaceuticals (XENE) | 1.2 | $24M | 600k | 39.37 | |
Immunovant (IMVT) | 1.2 | $24M | 825k | 28.51 | |
Kymera Therapeutics (KYMR) | 1.0 | $21M | 450k | 47.33 | |
Spyre Therapeutics Com New (SYRE) | 1.0 | $21M | 697k | 29.41 | |
Kura Oncology (KURA) | 1.0 | $20M | 1.0M | 19.54 | |
Kalvista Pharmaceuticals (KALV) | 0.9 | $18M | 1.6M | 11.58 | |
Nkarta (NKTX) | 0.9 | $18M | 4.0M | 4.52 | |
Oric Pharmaceuticals (ORIC) | 0.9 | $18M | 1.7M | 10.25 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.9 | $18M | 400k | 43.89 | |
Fate Therapeutics (FATE) | 0.9 | $17M | 5.0M | 3.50 | |
Enliven Therapeutics (ELVN) | 0.8 | $17M | 671k | 25.54 | |
Replimune Group (REPL) | 0.8 | $17M | 1.5M | 10.96 | |
Day One Biopharmaceuticals I (DAWN) | 0.8 | $17M | 1.2M | 13.93 | |
Cullinan Oncology (CGEM) | 0.7 | $15M | 908k | 16.74 | |
Arvinas Ord (ARVN) | 0.7 | $15M | 609k | 24.63 | |
Eliem Therapeutics (CLYM) | 0.7 | $13M | 2.6M | 5.09 | |
Relay Therapeutics (RLAY) | 0.6 | $13M | 1.8M | 7.08 | |
Nurix Therapeutics (NRIX) | 0.6 | $13M | 563k | 22.47 | |
Prothena Corp SHS (PRTA) | 0.6 | $12M | 690k | 16.73 | |
Uniqure NV SHS (QURE) | 0.5 | $11M | 2.2M | 4.93 | |
Apogee Therapeutics (APGE) | 0.5 | $11M | 179k | 58.74 | |
Olema Pharmaceuticals (OLMA) | 0.4 | $7.8M | 650k | 11.94 | |
Iovance Biotherapeutics (IOVA) | 0.3 | $7.0M | 750k | 9.39 | |
Century Therapeutics (IPSC) | 0.3 | $6.7M | 3.9M | 1.71 | |
Jasper Therapeutics Com New (JSPR) | 0.3 | $6.6M | 350k | 18.81 | |
Sana Biotechnology (SANA) | 0.3 | $6.4M | 1.5M | 4.16 | |
Terns Pharmaceuticals (TERN) | 0.3 | $6.3M | 752k | 8.34 | |
Scholar Rock Hldg Corp (SRRK) | 0.3 | $6.0M | 750k | 8.01 | |
Poseida Therapeutics I (PSTX) | 0.3 | $5.7M | 2.0M | 2.86 | |
Summit Therapeutics (SMMT) | 0.3 | $5.5M | 250k | 21.90 | |
Engene Holdings (ENGN) | 0.2 | $4.8M | 728k | 6.60 | |
Prelude Therapeutics (PRLD) | 0.2 | $3.5M | 1.7M | 2.07 | |
Bicara Therapeutics (BCAX) | 0.2 | $3.4M | 135k | 25.47 | |
Mersana Therapeutics (MRSN) | 0.2 | $3.4M | 1.8M | 1.89 | |
Boundless Bio (BOLD) | 0.1 | $2.5M | 711k | 3.47 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $2.2M | 506k | 4.35 | |
Zentalis Pharmaceuticals (ZNTL) | 0.1 | $1.7M | 450k | 3.68 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $1.5M | 812k | 1.83 | |
Health Sciences Acq Corp 2 (OBIO) | 0.1 | $1.2M | 238k | 5.14 | |
Zura Bio Class A Ord Shs (ZURA) | 0.1 | $1.2M | 300k | 4.06 | |
Bioatla (BCAB) | 0.1 | $1.2M | 686k | 1.76 | |
Milestone Pharmaceuticals (MIST) | 0.0 | $470k | 309k | 1.52 | |
DBV Technologies S A Sponsored Adr (DBVT) | 0.0 | $175k | 250k | 0.70 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $26k | 267k | 0.10 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.3k | 67k | 0.02 |